AI assistant
Sending…
ABEONA THERAPEUTICS INC. — Director's Dealing 2021
Apr 6, 2021
33413_dirs_2021-04-06_a356e1ae-c05e-4f4f-a2e1-f637947d5753.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-03-26
Reporting Person: Alvino Mark (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 5000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $113.50 | 2021-04-15 | Common stock (700) | Direct | |
| Stock Option (right to buy) | $30.50 | 2021-04-15 | Common stock (700) | Direct | |
| Stock Option (right to buy) | $18.50 | 2021-04-15 | Common stock (10000) | Direct | |
| Stock Option (right to buy) | $7.34 | 2021-04-15 | Common stock (75000) | Direct | |
| Stock Option (right to buy) | $4.45 | 2021-04-15 | Common stock (50000) | Direct | |
| Stock Option (right to buy) | $16.00 | 2021-04-15 | Common stock (30000) | Direct | |
| Stock Option (right to buy) | $7.42 | 2021-04-15 | Common stock (19827) | Direct |
Footnotes
F1: The options vested 100% six months after their respective grant dates.
More from ABEONA THERAPEUTICS INC.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 28
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27